Ventricular Tachycardia Target Site Identification Patent

EPO published patent application EP4388553A1 on March 25, 2026, disclosing methods for identifying target sites for ventricular tachycardia treatment. The patent covers computational/health informatics approaches (IPC G16H 50/50) and surgical planning methods (A61B 34/10) for arrhythmia treatment. Designated states include all 31 EPC contracting states covering major European markets.

This is a routine patent publication rather than a regulatory action, requiring no compliance steps from regulated entities. Healthcare providers, medical device manufacturers, and pharmaceutical companies involved in cardiac treatment research may wish to review this patent to assess potential licensing requirements or freedom-to-operate implications for related product development.